html5-img
1 / 7

LOOKING BACK, LOOKING FORWARD: The view from Health Boards

LOOKING BACK, LOOKING FORWARD: The view from Health Boards. Tom Divers, SMC Member and CE, NHS Greater Glasgow & Clyde. LOOKING BACK, LOOKING FORWARD: Budget Impact Analysis. Peripheral to SMC decision … but Central to NHS Planning SMC ‘Intelligence’ Submission Expert Comments

myra-snyder
Download Presentation

LOOKING BACK, LOOKING FORWARD: The view from Health Boards

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LOOKING BACK, LOOKING FORWARD:The view from Health Boards Tom Divers, SMC Member and CE, NHS Greater Glasgow & Clyde

  2. LOOKING BACK, LOOKING FORWARD:Budget Impact Analysis • Peripheral to SMC decision … but • Central to NHS Planning • SMC ‘Intelligence’ • Submission • Expert Comments • Support for SMC User Group Review • Consistent & transparent structure • Gross & net costs • Adaptable to local circumstances

  3. LOOKING BACK, LOOKING FORWARD:Patient and Public Involvement • Public Petitions Committee • Availability of and access to new medicines • Openness, clarity, transparency … Flowchart • Respective roles of national and local processes? • Distinctive contribution • Continuum for managed introduction of new medicines • Joint challenge for SMC & NHS Boards • Public perception of NHS prescribing? • Examples • Cancer medicines • Antimicrobial therapy

  4. LOOKING BACK, LOOKING FORWARDOrphan Drugs - A Wicked Issue? Often areas of greatest debate at SMC - less confident touch in decisions Cost-effectiveness is generally challenging Is it inevitable that decision-making is pushed down to NHS Board and individual patient level? Boards’ ‘risk-sharing’ arrangement is pragmatic ‘holding’ position

  5. LOOKING BACK, LOOKING FORWARD“Accepted for use” – Too broad a church? • Force of SMC decisions not well understood by some politicians and media - local ADTC now determines formulary status • ‘Unique’ status is rare attribution • ‘Accepted for use’: from elements of ‘unique’ to ‘me too’ • Is any finer gradation reasonable or possible? • Can we rely on maturity of ADTCs to ensure that important advances are implemented consistently?

  6. LOOKING BACK, LOOKING FORWARD:View from Health Boards • Evaluation success • Comprehensive horizon scanning • Timely ADTC advice • Effective communication networks • Challenges • Orphan medicines • Accepted for use … • Budget impact analysis • Public involvement • Future • Development of SMC / NHS B partnership

More Related